⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Eloxx Pharmaceuticals, Inc. Common Stock

$12.80
-0.44 (-3.32%)

Volume:

24.165K ($311.22K)

Market Capitalization:

$51.67M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Eloxx Pharmaceuticals Market Segments

Overnight

*No Trades in Segment

After Hours

+0.00(+0.00%)
Open$12.80
Close$12.80
Low$12.80
Low Change0.00 (0.00%)
High$12.80
High Change+0.00 (+0.00%)
Range$0.00
Volume289
Dollar Volume$3.70K

Regular Trading Hours

-1.12(-7.99%)
Open$14.00
Close$12.88
Low$12.87
Low Change-1.13 (-8.06%)
High$14.00
High Change+0.00 (+0.00%)
Range$1.13
Volume23.876K
Dollar Volume$307.52K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$13.12
Close$13.12
Low$13.12
Low Change0.00 (0.00%)
High$13.12
High Change+0.00 (+0.00%)
Range$0.00
Volume363
Dollar Volume$4.76K

Regular Trading Hours Yesterday

+0.03(+0.23%)
Open$13.21
Close$13.24
Low$12.64
Low Change-0.57 (-4.31%)
High$13.56
High Change+0.35 (+2.61%)
Range$0.92
Volume7.033K
Dollar Volume$93.12K

Premarket Yesterday

*No Trades in Segment

Eloxx Pharmaceuticals News

There is no current news for this stock at the moment.

Eloxx Pharmaceuticals Top Trades

Eloxx Pharmaceuticals's top trade so far today returned +0.08%, while the top short trade returned -8.56%.

Eloxx Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$13.07
10 Day Moving Average (SMA10)$13.25
20 Day Moving Average (SMA20)$14.28
50 Day Moving Average (SMA50)$16.03
100 Day Moving Average (SMA100)—
200 Day Moving Average (SMA200)—

Eloxx Pharmaceuticals Statistics

Average Volume (30 Days)27.67K
P/E Ratio (Current)-3.33
EPS (Current)-$4.12
Dividend Yield0.00%
Free Cash Flow—
Cash Ratio0.05
Current Ratio0.07
Quick Ratio0.07
Debt to Equity-0.17
Enterprise Value$49.96M
EV to EBITDA-3.93
EV to Sales—
Price to Book-2.09
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-8.27%
Return on Equity0.63%

Eloxx Pharmaceuticals Stock Splits

There have been 2 stock splits for Eloxx Pharmaceuticals (ELOX). The last reverse stock split occured on June 1, 2026 and reduced the outstanding shares at a ratio of 11:1.

DateTypeRatio
Jun 1, 2026Reverse11:1
Dec 2, 2022Reverse40:1

Eloxx Pharmaceuticals Dividends

There have been no dividends for Eloxx Pharmaceuticals (ELOX).